Victoria Delgado
Latest contributions
Echocardiographic guide on tricuspid valve interventions
05 Sep 2025
Master anatomy, imaging views, and procedural guidance with this comprehensive echocardiographic reference for tricuspid interventions.
Latest learnings on the treatment of asymptomatic severe aortic stenosis from the EARLY TAVR
22 May 2025 – From EuroPCR 2025
At EuroPCR 2025, Christopher Cook, Philippe Genereux, and Victoria Delgado discuss key results from the EARLY TAVR study.
In asymptomatic patients with severe aortic stenosis, early intervention was associated with significantly less cardiac damage at 2 years, compared to a surveillance strategy that led to extensive damage...
PCR Tricuspid Focus Group - Referral Meeting en Barcelona
23 Jun 2025
Join your peers for this meeting on 10 October 2025 in Barcelona, Spain!
Are we undertreating aortic regurgitation?
20 May 2025 – From EuroPCR 2025
At EuroPCR 2025, Victoria Delgado, Helge Möllmann, and Dan Blackman gather to discuss a crucial but often under-addressed challenge in structural heart disease: the under-referral and under-treatment of patients with aortic regurgitation (AR).
The conversation begins with the diagnostic challenges surrounding severe AR, followed by a striking observation—only...
Assessment and management of patients with multivalvular disease involving the tricuspid valve
22 May 2025 – From EuroPCR 2025
Gain expertise on managing multivalvular disease involving the tricuspid valve by understanding diagnostic challenges, intervention indications, and associated pathophysiological factors. This session includes complex case studies focusing on combined valvular lesions and guideline limitations.
Percutaneous And Non-fluoroscopic Procedures (PAN): promoting equality and radiation-free intervention
22 May 2025 – From EuroPCR 2025
Discover innovative non-fluoroscopic interventional techniques with the Percutaneous And Non-fluoroscopic Procedures (PAN) session. Learn how to perform radiation-free interventions using advanced technologies, assess their clinical equivalence to standard methods, and explore how these procedures may promote gender equality in interventional cardiology careers.
Enhancing clipping solutions for durable long-term patient outcomes
21 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session delves into the evolving strategies for mitral and tricuspid TEER, backed by fresh data and real-world insights. Review the latest evidence from the TRILUMINATE Pivotal and bRIGHT studies, and see how TR phenotypes can guide patient selection for more durable outcomes. Discover...
Decompensated heart failure: indication and management of mechanical circulatory support
20 May 2025 – From EuroPCR 2025
This session reviews state-of-the-art strategies for managing life-threatening acute heart failure, focusing on indications and management of mechanical circulatory support, including cases like young myocarditis. Learn contemporary approaches for patients after mechanical circulatory support removal through interactive case discussions.
Advancing transcatheter solutions for tricuspid valve disease
01 Feb 2025 – From PCR Imaging Valves Madrid 2025
This session delves into the latest advancements in transcatheter tricuspid valve interventions, covering procedural considerations, patient selection, and imaging techniques. Explore case studies, strategies for tricuspid transcatheter edge-to-edge repair, and key criteria for valve replacement. Learn about managing failed T-TEER cases and the role of transcatheter...
Navigating complexities in multivalvular heart disease: risk stratification, intervention timing, and advanced imaging
01 Feb 2025 – From PCR Imaging Valves Madrid 2025
This session explores the challenges of managing mixed and multiple valvular heart diseases, focusing on risk stratification, treatment decisions, and transcatheter intervention timing. Experts discuss assessing and treating aortic and mitral paravalvular leaks, as well as managing mitral annular calcification, using case studies to guide optimal...
Mastering mitral valve disease: diagnosis, management, and intervention
31 Jan 2025 – From PCR Imaging Valves Madrid 2025
Dive into this comprehensive session on mitral valve disease, covering key aspects of diagnosis, classification, assessment, management, and patient selection for transcatheter intervention. Gain in-depth knowledge through real-world case studies and multidisciplinary team discussions, equipping you with essential skills to optimize patient care.
Advancing imaging and intervention strategies for mitral valve disease
31 Jan 2025 – From PCR Imaging Valves Madrid 2025
Explore the latest imaging techniques for transcatheter mitral valve interventions, including patient screening, device selection, and strategies for challenging anatomies. Gain insights into TEER and transcatheter mitral valve replacement to optimize patient outcomes.
Taking the next step in the evolution of aortic regurgitation treatment
31 Jan 2025 – From PCR Imaging Valves Madrid 2025
Explore the latest in aortic regurgitation treatment, including a TAVI case with the Trilogy device, imaging challenges, and future advancements like CMR and guideline updates.
Aortic valve disease - Aortic stenosis management: Diagnosis, classification & treatment strategies
31 Jan 2025 – From PCR Imaging Valves Madrid 2025
This comprehensive session explores the latest advancements in classifying and managing aortic stenosis. Learn key techniques for assessing severity, even in complex cases, and gain insights into evaluating asymptomatic patients with severe disease. Discover multi-modality imaging approaches for diagnosing and treating bicuspid aortic valve, along with...
Aortic valve disease – Imaging strategies for optimal valve selection and outcomes in TAVI
31 Jan 2025 – From PCR Imaging Valves Madrid 2025
Dive into this in-depth session on aortic valve disease, covering essential imaging insights for selecting the ideal TAVI prosthesis, identifying risk markers for pacemaker implantation, and optimizing outcomes in complex cases. Learn how multi-modality imaging aids in diagnosing and managing bioprosthetic valve dysfunction, including detecting patient-prosthesis...
Focus on Imaging - PCR London Valves 2024
Victoria Delgado and Nina Wunderlich delve into the imaging highlights from PCR London Valves 2024, emphasizing the critical role of advanced imaging for structural interventions. They spotlight the importance of emerging technologies in achieving precise, well-dosed procedures. A standout feature is the Imaging Learning Centre, offering...
Recurrent and residual tricuspid regurgitation after transcatheter repair - Assessment and management
26 Nov 2024 – From PCR London Valves 2024
Join us as we delve into the critical topic of recurrent and residual tricuspid regurgitation after transcatheter repair. Gain valuable insights on how to avoid these complications, learn to assess the underlying mechanisms and severity, and explore the latest options for interventional treatment. This session, developed...
Valve haemodynamics and long-term durability
26 Nov 2024 – From PCR London Valves 2024
Curious about valve durability and haemodynamics? This session is for you!
You'll discover why echocardiographic and invasive measurements of valve gradients differ, gain insights into the performance of surgical versus transcatheter valves, explore the latest knowledge on structural valve degeneration and learn how interventional techniques may influence...
New frontiers in TAVI: have we reached them?
25 Nov 2024 – From PCR London Valves 2024
Discover the latest advancements in TAVI as we look into the results of the EARLY TAVR and RHEIA trials. Explore how these groundbreaking findings may influence clinical practice guidelines and shape the future of TAVI, as well as the remaining unmet clinical needs in TAVI.
Mastering structural heart intervention with innovations in imaging
25 Nov 2024 – From PCR London Valves 2024
Explore the future of transcatheter mitral and tricuspid therapies in this innovative session. Learn how advanced imaging techniques like CT/fluoro fusion and 4D intracardiac echocardiography are revolutionizing complex procedures, enhancing both safety and outcomes. Hear from experienced operators as they share their insights on the evolving...
The TRI.Fr trial: how will it impact my practice?
19 Jul 2024
Watch the replay of this webinar to get the main results from the TRI-FR trial, along with interventional and heart valve disease specialist interpretations based on the existing evidence!
Asymptomatic severe aortic stenosis: Will these trials change my practice?
16 May 2024 – From EuroPCR 2024
This session, in collaboration with Partners in Learning, explores the emerging evidence on the use of transcatheter aortic valve implantation (TAVI) in patients with asymptomatic severe aortic stenosis. It covers data from registries and randomized controlled trials, the current guideline recommendations, and the potential impact of...
Expanding the heart team - Improved TAVI outcomes through pre-and post-procedure collaboration
16 May 2024 – From EuroPCR 2024
In this session, learn how to advance heart team collaboration through optimized TAVI pre-work-up and refined severe aortic stenosis patient selection, ensuring accurate intervention indications. Gain hands-on insights for effective post-TAVI strategies, explore procedural and valve refinements that simplify post-TAVI PCI, and stay informed on the...
How does the female heart respond to severe aortic stenosis and aortic intervention?
15 May 2024 – From EuroPCR 2024
In this session, gain insights into the gender-specific differences among patients with aortic stenosis (AS) and their implications for treatment strategies. Explore the significance of hemodynamics and durability from a patient's perspective, shedding light on the importance of personalized care. Engage in discussions about the optimal...
Heterotopic tricuspid valves: to who, when and how?
15 May 2024 – From EuroPCR 2024
Watch this session to gain comprehensive insights into the use, safety, and efficacy of heterotopic tricuspid valves. Learn to identify ideal candidates with severe tricuspid regurgitation, understand key procedural factors for successful implantation, and receive tips on valve systems and anatomy. The session also includes...
lmaging: The eyes of the Heart Team
14 May 2024
More than ever, Heart Team members rely on advanced imaging to guide procedures and aid in decision-making about patient selection and management. Just as imaging plays a prominent role in the cathlab, so it will be central to this year's EuroPCR content, with a track of specially...
Asymptomatic severe aortic stenosis, how will new evidence change our practice?
15 May 2024 – From EuroPCR 2024
Victoria Delgado and Martin Leon discuss how to treat patients with asymptomatic severe aortic stenosis at an earlier stage and how current trials may change our practice in the future and broaden the indications.
This interview was filmed at EuroPCR 2024: see more videos here.
Tricuspid valve disease: diagnosis and classification
03 Feb 2024 – From PCR Imaging Valves Madrid 2024
Discover, in this comprehensive 3rd episode of PCR Imaging Valves Madrid 2024, the nuances of diagnosing and grading tricuspid valve disease, including insights into normal and abnormal function post-repair or replacement, the pivotal role of imaging in valve quantification and device selection, strategies for assessing right ventricular...
Multivalvular disease: mitral and aortic valve challenges explored
03 Feb 2024 – From PCR Imaging Valves Madrid 2024
Explore cutting-edge transcatheter valve interventions for mitral and aortic valve disorders, including valve-in-valve procedures and management strategies for paravalvular leakages, and learn about diagnosing and treating mitral annular calcification and transcatheter options in infective endocarditis.
Multivalvular disease: diagnostic challenges and treatment strategies for aortic and mitral valve disorders
03 Feb 2024 – From PCR Imaging Valves Madrid 2024
Addressing the complex diagnostic challenges in aortic stenosis and regurgitation, this session examines the timing of treatment initiation and the decision-making process when aortic valve disease coincides with aortic pathology. It also explores the ongoing healthcare burden posed by mitral regurgitation and stenosis, emphasizing the importance...
